JGJuliana Gebb

Juliana Gebb

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Juliana Gebb has a total of 137 co-authors. Here are the top co-authors by number of shared publications:

  • Nahla Khalek

    Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment Children's Hospital of Philadelphia Philadelphia Pennsylvania USA

    7 shared publications
  • Julie S. Moldenhauer

    Nemours Institute for Maternal Fetal Health, Nemours Children's Hospital, Orlando, Florida, USA

    6 shared publications
  • Shelly Soni

    Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment Children's Hospital of Philadelphia Philadelphia Pennsylvania USA

    6 shared publications
  • Edward R. Oliver

    Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment Children's Hospital of Philadelphia Philadelphia Pennsylvania USA

    5 shared publications
  • Christina Paidas Teefey

    Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment Children's Hospital of Philadelphia Philadelphia Pennsylvania USA

    4 shared publications
  • Beverly G. Coleman

    Division of Neurology Department of Pediatrics Children's Hospital of Philadelphia Perelman School of Medicine at University of Pennsylvania Philadelphia Pennsylvania USA

    3 shared publications

Latest Publications

  • Open Access

    Diagnostic Yield of Sequencing in Prenatal Agenesis of the Corpus Callosum in a Well‐Phenotyped International Cohort

    by Lorraine Dugoff, Natalie Chandler, Stephanie Allen, Sarah A. Graham, Vicki Harrison, Anne McCabe, Anna de Burca, Audrey Smith, Erina Sasaki, Mairead Hagarty, et al.

    Objective: To evaluate the incremental diagnostic yield of sequencing in a large, well‐phenotyped international cohort of fetuses with prenatally diagnosed agenesis of the corpus callosum (ACC) and to identify associated genes and variants. Methods: Retrospective multicenter cohort study of fetuses with a prenatal diagnosis of ACC undergoing sequencing after nondiagnostic chromosomal microarray. Clinical data were obtained from prenatal ultrasound and fetal MRI reports. Cases were classified as isolated ACC, ACC with additional central nervous system (CNS) abnormalities, or ACC with extracranial abnormalities. Variants were classified according to the ACMG or ACGS criteria. Results: Among 321 fetuses with ACC, a pathogenic or likely pathogenic (P/LP) variant was identified in 97 cases (30.2%). Diagnostic yield increased with phenotypic complexity: 17.3% in isolated ACC, 25.7% in ACC with additional CNS abnormalities, and 41.0% in ACC with extracranial abnormalities. MRI confirmation was available in 249 cases (77.6%) and did not alter overall diagnostic yield of genetic testing. No significant difference in yield was observed between complete ACC and other ACC types. P/LP variants were identified in 51 genes, most frequently TUBA1A . Conclusion: Sequencing provides substantial diagnostic yield in prenatally diagnosed ACC, particularly when additional CNS or extracranial anomalies are present. These findings support the use of exome or genome sequencing in the prenatal evaluation of ACC and emphasize the importance of detailed phenotyping to improve classification, interpretation and counseling.

  • Open Access

    Characteristics and outcomes of monochorionic diamniotic twin pregnancies complicated by selective fetal growth restriction with intermittent absent end diastolic flow

    by Juliana S. Gebb, Alekhya Jampa, Violetta Bakunina, Yunliang Zhao, Kiersten Barr, Federica Bellussi, Desiree Fiorentino, Suzanne DeBari, Edward R. Oliver, Nahla Khalek, et al.

    Introduction: Monochorionic diamniotic twins with selective fetal growth restriction (sFGR) are categorized based on the umbilical artery (UA) end diastolic flow (EDF) of the growth‐restricted fetus. While persistent flow abnormalities are attributed to placental insufficiency, intermittent flow changes are often attributed to anastomoses. We hypothesized that not all intermittent flow is due to anastomotic fluctuation and sought to determine if pregnancies with intermittent forward and absent EDF may represent a unique cohort of sFGR pregnancy. Methods: Retrospective analysis of prospectively collected data from a monochorionic pregnancy registry. Records of patients with monochorionic diamniotic twins with sFGR evaluated from January 2013 to December 2024 were reviewed. sFGR was defined by the Delphi‐based consensus criteria. Pregnancies were grouped by the umbilical artery Doppler of the smaller fetus: (1) Type I: persistent forward EDF (+EDF); (2) Type II: no forward EDF (A/REDF); (3) Type IIIa: intermittent forward and absent EDF (iAEDF); or (4) Type IIIb: intermittent forward, absent, and reversed EDF (iAREDF). Pregnancy characteristics were compared between groups and outcomes were then compared in expectantly managed patients. Results: Of 330 patients with sFGR, 114 (34.5%) had +EDF (Type I), 70 (21.2%) had A/REDF (Type II), 90 (27.3%) had iAEDF (Type IIIa), and 56 (17.0%) had iAREDF (Type IIIb). Gestational age at first evaluation was lower in those with Type II compared to Type IIIb ( p = 0.003) and fetal intervention was higher in patients with any absent or reversed EDF compared to those with +EDF ( p < 0.001). In expectantly managed patients ( n = 189), median gestational age at delivery in weeks was higher in patients with Type I (32.5) and Type IIIa (32.4) compared to those with Type II (27.4) and Type IIIb (29.1) (Type I vs. Type II, p < 0.001; Type I vs. Type IIIa, p = 0.319; Type I vs. Type IIIb, p < 0.001; Type II vs. Type IIIa, p = 0.003; Type II vs. Type IIIb, p = 0.598; Type IIIa vs. Type IIIb, p < 0.001). Additionally, dual survival to discharge was higher in those with Type I compared to Type II ( p < 0.001) but not compared to Type IIIa ( p = 0.292) or Type IIIb ( p = 0.262). Conclusion: Patients with sFGR and intermittent absent EDF may represent a unique cohort with outcomes more similar to those with +EDF than those with intermittent forward, absent, and reversed EDF.

  • Open Access

    Stratification of Phenotypes in Childhood-Onset COL4A1/COL4A2 –Related Disorders Based on Age of Presentation

    by Giulia S. Porcari, Rudmila N. Rashid, Caitlyn A. Mulvihill, Lauren A. Beslow, Holly A. Dubbs, Erica M. Schindewolf, Michael C. Kaufman, Alexander K. Gonzalez, Juliana S. Gebb, Sonika Agarwal, et al.

    Variants in COL4A1 and COL4A2 are associated with a multisystem disorder characterized by prominent neurologic involvement that includes intracranial hemorrhages, white matter injury, neurodevelopmental impairment, and epilepsy. The phenotypic spectrum, however, is broad, and disease subgroups have not been robustly identified. The objective of this study was to distinguish pediatric subgroups based on age at symptom onset. This was a retrospective cohort study of pediatric patients with variants in COL4A1 or COL4A2 seen at a single center between January 2008 and October 2024. Patients were included if they had likely pathogenic/pathogenic variants or variants of uncertain significance with consistent clinical phenotype and were followed for ≥6 months. Medical records, laboratory data, and neuroimaging were reviewed. Patients were stratified by age at symptom onset into perinatal, early childhood, and late childhood onset (up to 28 days, up to 4 years, and up to 18 years, respectively). Of the 44 patients meeting inclusion criteria, 33 had variants in COL4A1, 10 in COL4A2, and 1 in both. Neurologic features, such as global developmental delay, cerebral palsy, and epilepsy, were common in perinatal and early childhood cases. In COL4A1-related disease, such neurologic features were present in 14/17 and 8/9 cases, respectively. These features similarly occurred in all patients with perinatal (n = 3) and early childhood (n = 6) onset of COL4A2-related disease. Conversely, these manifestations were less common in late childhood presentations of either disorder (n = 6 total), occurring in 33% of patients. Extracentral nervous system manifestations, particularly ocular abnormalities and renal disease, were predominantly seen in COL4A1-related disease. Neuroimaging in perinatal and early childhood presentations frequently demonstrated periventricular hemorrhagic infarction (20/26 and 6/9 of COL4A1 and COL4A2 patients). Isolated leukoencephalopathy was universally present in late childhood onset patients. The pediatric phenotype of COL4A1/2-related disorder varies by age at disease onset. Perinatal and early childhood presentations (≤4 years) have a prominent neurologic phenotype with severe developmental delays, cerebral palsy, and epilepsy, correlating on imaging with sequelae from brain injury during prenatal brain development. Late childhood presentations (>4 years) have a milder phenotype, typically with isolated leukoencephalopathy on imaging.


  • Open Access

    A predictive scoring model for perinatal loss in monochorionic diamniotic twins with selective fetal growth restriction managed expectantly

    by Shelly Soni, Leny Mathew, Nahla Khalek, Desiree Fiorentino, Alekhya Jampa, Edward R. Oliver, Juliana Gebb

    Objective: To establish a clinically applicable prenatal scoring system to predict perinatal loss in monochorionic diamniotic (MCDA) twins with selective fetal growth restriction (sFGR). Methods: We performed a retrospective cohort study of MCDA twins with sFGR and managed expectantly at a single fetal therapy center between 2010 and 2024. Pregnancies with incomplete documentation, missing delivery records, spontaneous preterm birth, or well‐documented cervical insufficiency were excluded. Perinatal loss was defined as the loss of one or both fetuses or neonates within a single pregnancy. Demographic, sonographic, and outcome variables were compared between pregnancies with and without perinatal loss. Multivariable logistic regression with a priori selected variables was used to identify predictors of perinatal loss. Backward elimination was performed using nested likelihood ratio testing, and variance inflation factors were assessed for multicollinearity. Odds ratios from the final model were used to construct an additive risk score. Receiver operating characteristic (ROC) curve analysis with maximization of the Youden index was used to identify optimal score thresholds. Results: Among 222 pregnancies with sFGR, 181 met inclusion criteria, including 132 Type I, 23 Type II, and 26 Type III cases. Perinatal loss occurred in 10%, 26%, and 15% of these subtypes, respectively, with an overall loss rate of 12.7% (23/181). Pregnancies with perinatal loss had greater intertwin estimated fetal weight (EFW) discordance (36% vs. 29%, p = 0.001), a higher prevalence of abnormal middle cerebral artery (MCA) Dopplers (39.1% vs. 10.7%, p < 0.0001) in the growth‐restricted fetus (GRF), and earlier gestational age at delivery (27.4 vs. 32.4 weeks, p < 0.0001). Two predictive models with comparable likelihood ratios were identified. Model 1 included intertwin EFW discordance ≥33%, abnormal umbilical artery (UA) and MCA Dopplers, EFW < 3rd percentile, and fetal female sex (protective), achieving an area under the curve (AUC) of 0.80 with 82% sensitivity and 70% specificity at a score threshold of 10. Model 2 excluded fetal sex and yielded an AUC of 0.75 with 61% sensitivity and 83% specificity at a threshold of 9. Conclusion: A clinically applicable prenatal scoring system incorporating EFW discordance, UA and MCA Doppler abnormalities in the GRF, EFW < 3rd percentile, and fetal sex can assist in predicting perinatal loss in MCDA twins with sFGR. This model may improve risk stratification and support counseling and shared decision‐making. The limited number of Type II and Type III cases restricts conclusions regarding performance across all sFGR subtypes.

  • Prenatal Closure of Myeloschisis vs Myelomeningocele: Insights From the fMMC Consortium Registry

    by David S. Hersh, Amirul Anuar, Jagruti Anadkat, Kelly A. Bennett, Yair J. Blumenfeld, Christopher Q. Buchanan, Caitlin M. Clifford, Stephen P. Emery, Juliana S. Gebb, William H. Goodnight, et al.

    BACKGROUND AND OBJECTIVES: Myelomeningocele is defined by the presence of a fluid-filled sac that contains the neural placode and cerebrospinal fluid (CSF) at the level of the spinal defect. Alternatively, the term myeloschisis is used when the neural placode is not contained within a CSF-filled sac. While both are eligible for prenatal closure, few studies have characterized the impact of the type of lesion on postnatal outcomes. This study compares the outcomes of these 2 types of open spinal dysraphism using data from the Fetal Myelomeningocele Consortium registry sponsored by the North American Fetal Therapy Network. METHODS: The prospective observational Fetal Myelomeningocele Consortium registry was used to extract deidentified data corresponding to patients who underwent fetal closure of myelomeningocele vs myeloschisis. Demographics, operative characteristics, perioperative complications, and postnatal outcomes were collected. RESULTS: A total of 1327 patients were identified, including 991 (74.7%) with myelomeningocele and 336 (25.3%) with myeloschisis. Compared with myelomeningocele, myeloschisis was associated with lower rates of prenatal talipes (11% vs 24%, P < .001) and higher rates of favorable prenatal movement (94% vs 86%, P < .001). Postnatally, myeloschisis conferred higher rates of leg movement (97% vs 90%, P = .002) and an increased likelihood of ambulation in the household (10.4% vs 4.1%, P = .009) and outside (7.2% vs 1.9%, P = .004) at 1 year. However, myeloschisis was also linked to greater use of skin patches during closure (49% vs 27%, P < .001), higher CSF leak rates among those with wound dehiscence (26% vs 8%, P = .014), and more frequent CSF diversion and tethered cord surgeries at follow-up. CONCLUSION: Myeloschisis and myelomeningocele demonstrate distinct clinical profiles. Although patients with myeloschisis may have favorable motor outcomes, they are also characterized by higher rates of CSF leakage, CSF diversion, and tethered cord surgery. These findings highlight the need for lesion-specific prognostication and may inform surgical planning and parental counseling in the context of prenatal spina bifida closure.


  • Open Access

    Assessment of fetal endometrial thickness: a key to the prenatal diagnosis of ovarian cysts

    by Minh-Huy Huynh, Laura De Leon Benedetti, Leny Mathew, Mohamed K Mohamed, Edward R Oliver, Suzanne E Debari, Juliana S Gebb, Nahla Khalek, Shelly Soni, Desiree Fiorentino, et al.

    Background: Fetal abdominopelvic cysts are relatively common, but distinguishing ovarian from non-ovarian cysts prenatally remains challenging because morphologic features overlap, and no imaging marker has been validated. Objective: To evaluate fetal endometrial thickness and cyst volume as imaging markers for the prenatal diagnosis of ovarian cysts. Materials and methods: We conducted a single-center, retrospective study of female fetuses with abdominopelvic cysts diagnosed on prenatal ultrasound and/or magnetic resonance imaging (MRI) between January 2010 and December 2024. Two blinded pediatric radiologists independently measured endometrial thickness and cyst volume, with discrepancies resolved by consensus. Postnatal confirmation of diagnosis was obtained through imaging, surgical pathology, or clinical follow-up. Statistical analyses included regression models adjusted for gestational age and receiver operating characteristic (ROC) analysis. Results: A total of 63 fetuses met inclusion criteria (40 ovarian cysts, 23 non-ovarian cysts) between 21 weeks and 40 weeks of gestation. Fetuses with ovarian cysts underwent ultrasound at later gestational ages than those with non-ovarian cysts (median, 35.0 weeks vs. 27.9 weeks; P P P P P P =0.36). Endometrial thickness remained independently associated with ovarian cysts after adjustment for gestational age (ultrasound coefficient, 1.56 [95% CI, 0.84–2.26]; MRI coefficient, 0.81 [95% CI, 0.41–1.21]). ROC analysis demonstrated excellent diagnostic performance, with an ultrasound threshold of 1.9 mm yielding 100% sensitivity and specificity (AUC, 1.00 [95% CI, 1.00–1.00]). In contrast, cyst volume showed only moderate discriminatory ability (AUC, 0.82 [95% CI, 0.71–0.93]). Conclusion: Fetal endometrial thickness is a robust imaging marker for the prenatal diagnosis of ovarian cysts. Incorporating this parameter into routine prenatal imaging may enhance diagnostic accuracy, guide counseling, and improve perinatal management. Graphical

  • Hydroxychloroquine After Complete Heart Block Diagnosis and Relationship to Patient Outcomes: A Descriptive Cohort Study

    by Elizabeth L. Carter, Juliana Gebb, Christopher Janson, Anita Szwast

    Objective: Congenital complete heart block (CHB) carries significant morbidity and mortality. Maternal Hydroxychloroquine may prevent CHB in subsequent pregnancies. No studies have explored the benefit of Hydroxychloroquine initiated after the diagnosis of CHB. We hypothesized fetuses exposed to Hydroxychloroquine, even after CHB diagnosis, will have improved outcomes using time to pacemaker placement as the primary outcome. Methods: A single‐center retrospective study was conducted on patients with CHB secondary to maternal anti‐SSA antibodies approximately 2005–2024. Results: All patients ( n = 42) received prenatal Dexamethasone. Twenty‐four patients received prenatal Dexamethasone + Hydroxychloroquine; nine were started on Hydroxychloroquine prior to CHB diagnosis, while 15 were started on Hydroxychloroquine after diagnosis. Fetal hydrops occurred more in patients treated with Dexamethasone alone ( p = 0.004). Oligohydramnios occurred more in patients on Dexamethasone + Hydroxychloroquine ( p = 0.003). There was a higher likelihood of pacing at birth in the Dexamethasone only group ( p = 0.045), but no further significant differences in timing to pacemaker placement. Long‐term survival was similar. Conclusion: Increased rates of hydrops fetalis and the need for pacing at birth in the Dexamethasone only group suggest a possible positive effect of Hydroxychloroquine in utero, even if administered after the diagnosis of CHB. This study is limited by the small sample size and the inability to control for covariates. Further multicenter studies would help explore whether adjunctive treatment with Hydroxychloroquine improves outcomes, even when initiated after CHB diagnosis.


  • Agenesis of Corpus Callosum: A Clinical Study of Complete Versus Partial Agenesis in a 20-Year Retrospective Cohort

    by Rudmila Rashid, Ashley Bach, Juliana Gebb, Shelly Soni, Virali Patel, Khushboo Saha, Kendra Miller, Erica Schindewolf, Ana G. Cristancho, Sonika Agarwal

    Agenesis of the corpus callosum (ACC) has a wide spectrum of anatomic manifestations associated with incompletely understood clinical variability. In this retrospective cohort study, 161 children with ACC were classified into complete ACC and partial ACC. Partial and complete ACC diagnoses were confirmed by postnatal magnetic resonance imaging (MRI) and further classified as isolated or complex (associated with other brain abnormalities or genetic diagnoses). Clinical characteristics, clinical outcomes, and co-occurring genetic variations were collected by chart review. Median age at last neurologic evaluation for the complete and partial ACC cohorts were 2.8 years and 2.3 years, respectively; thus, an average of 2-3 years of follow-up data were analyzed per patient. Results showed that children with complete and partial ACC had similar birth characteristics. Children with complete ACC were more frequently diagnosed prenatally; additionally, complete ACC patients had lower rates of cerebral palsy. When comparing complex complete ACC and complex partial ACC to isolated complete ACC and isolated partial ACC, respectively, the complex subcohorts had a higher level of motor delay, assistive device use, cerebral palsy, ventriculoperitoneal shunt placement, epilepsy, language delay, and cognitive delay than the isolated subcohorts. About 50% of children had genetic variants associated with neurodevelopmental disorders in this cohort. Additionally, >50% of our patients with motor and nonmotor developmental delays, as well as >60% of patients that required assistive devices and had cerebral palsy, were also found to have genetic anomalies. Although research describing ACC and its outcomes is expanding, there is still a need for large cohort studies with robust follow-up data to help further understand the disease.


  • Open Access

    Selective Fetoscopic Laser Photocoagulation of Placental Anastomoses Leads to Early Reduction of Cardiovascular Burden in the Twin‐Twin Transfusion Syndrome

    by Kasey J. Chaszczewski, Sarah Perelman, Christine B. Falkensammer, Anita Szwast, Chengcheng Pang, Zhiyun Tian, Juliana Gebb, Julie Moldenhauer, Nahla Khalek, Jack Rychik

    Objective: Cardiovascular disturbances are common in twin‐twin transfusion syndrome (TTTS). However, the rate of improvement in cardiovascular burden in response to selective fetoscopic laser photocoagulation (SFLP) is not well known.Method: Fetal echocardiograms were performed prior to and 1 week following SFLP. Cardiovascular burden was characterized using the Children's Hospital of Philadelphia (CHOP) TTTS Cardiovascular (CV) Score. Pulsatility indices (PI) of the umbilical artery (UA) and middle cerebral artery (MCA), cerebroplacental ratio (CPR) and elements of CHOP CV Score were analyzed pre and post SFLP.Results: SFLP was performed in 198 subjects; 17 were excluded due demise post SFLP. Following SFLP, recipient (R) demonstrated an increase in MCA PI and a decrease in UA PI, with an increase in CPR. Donor (D) demonstrated a similar magnitude decrease in MCA PI and UA PI, yielding no change in CPR. Following SFLP, the mean CHOP CV Score decreased. The magnitude of change was greater in the subgroup with greater pre‐SFLP cardiovascular burden (CHOP CV Score ≥ 6).Conclusion: Improvement in CV burden is seen as early as 1‐week post‐SFLP, supporting acute alteration of loading conditions as a significant contributor. Further study of the trajectory of CV alterations may provide insight into the complex mechanisms underlying TTTS.

  • Open Access

    Observed/Expected Lung‐To‐Head Ratio and Total Lung Volumes That Identify Fetuses With Severe Congenital Diaphragmatic Hernia in a North American Fetal Center

    by Juliana Gebb, Sabrina Flohr, Leny Mathew, Edward R. Oliver, Kiersten Barr, Taryn Gallagher, Thomas A. Reynolds, Anne Ades, Natalie Rintoul, K. Taylor Wild, et al.

    Objective: To define the ultrasound observed/expected lung‐to‐head ratio (O/E LHR) and magnetic resonance imaging (MRI) observed/expected total lung volume (O/E TLV) cut‐offs associated with survival and lack of extracorporeal membrane oxygenation (ECMO) utilization to determine the most severe cohort that may benefit from fetal intervention.Methods: Retrospective review of patients with a prenatal diagnosis of isolated left or right congenital diaphragmatic hernia (L CDH, R CDH) seen and delivered at our level III fetal center from January 2013–July 2023. Data were extracted from our clinical outcome database. Characteristics of survivors and non‐survivors were compared for both the L CDH and R CDH groups. For both O/E LHR and O/E TLV, the Youden criteria were then used to determine a good sensitivity and specificity for predicting survival and ECMO utilization for L and R CDH, respectively, in Receiver Operator Characteristic (ROC) curve analysis.Results: 340 patients were included in the study, including 283 (83.2%) with L CDH and 57 (16.8%) with R CDH. The median [interquartile range, IQR] O/E LHR for L and R CDH was 37.9 [28.7–47.3] and 49.0 [40.0–64.5], respectively. The median O/E TLV for L and R CDH was 36.0 [28.0–48.0] and 25.3 [23.6–29.8], respectively. For survival, an O/E LHR of 28.1% and O/E TLV of 34.0% and an O/E LHR of 46.8% and O/E TLV of 17.6% were the best cut‐offs for L and R CDH, respectively. For ECMO utilization, an O/E LHR of 32.8% and O/E TLV of 35.3% and an O/E LHR of 47.0% and O/E TLV of 22.0% were the best cut‐offs for L and R CDH, respectively.Conclusion: We report the best ultrasound O/E LHR and MRI TLV cut‐offs associated with survival and lack of ECMO utilization in our cohort.